Literature DB >> 11384695

Prolonged pregnancy: induction of labor and cesarean births.

J M Alexander1, D D MCIntire, K J Leveno.   

Abstract

OBJECTIVE: To determine the effects of labor induction on cesarean delivery in post-date pregnancies.
MATERIALS AND METHODS: A total of 1325 women who reached 41 weeks' gestation between December 1, 1997, and April 4, 2000, and who were scheduled for induction of labor at 42 weeks were included in this prospective observational study. Cesarean delivery rates were compared between those women who entered spontaneous labor and those who underwent induction. Women with any medical or obstetric risk factors were excluded. A power analysis was performed to determine how many patients would be required to show no effect of labor induction on cesarean delivery with a beta of.8 and an alpha of.05. Approximately 5200 patients would be required, taking an estimated 28 years to accrue at our institution.
RESULTS: Admission to delivery was longer (5.7 compared with 11.1 hours, P =.001) and more likely to extend beyond 10 hours (55 compared with 24%, P =.001) in the induction group. Cesarean deliveries were increased in the induced group (19 compared with 14%, P <.001) due to cesarean for failure to progress (14 compared with 8%, P <.001). Independent risk factors for cesarean delivery included nulliparity, undilated cervix prior to labor, and epidural analgesia. Correction for these risk factors using logistic regression analysis revealed that it was the risk factors, and not induction of labor per se, that increased cesarean delivery.
CONCLUSION: Risk factors intrinsic to the patient, rather than labor induction itself, are the cause of excess cesarean deliveries in women with prolonged pregnancies.

Entities:  

Mesh:

Year:  2001        PMID: 11384695     DOI: 10.1016/s0029-7844(01)01354-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  The impact of the active management of risk in pregnancy at term on birth outcomes: a randomized clinical trial.

Authors:  James M Nicholson; Samuel Parry; Aaron B Caughey; Sarah Rosen; Allison Keen; George A Macones
Journal:  Am J Obstet Gynecol       Date:  2008-05       Impact factor: 8.661

2.  The association between increased use of labor induction and reduced rate of cesarean delivery.

Authors:  James M Nicholson; Peter Cronholm; Lisa C Kellar; Morghan H Stenson; George A Macones
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

3.  A preventive approach to obstetric care in a rural hospital: association between higher rates of preventive labor induction and lower rates of cesarean delivery.

Authors:  James M Nicholson; David L Yeager; George Macones
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

4.  Acupuncture to initiate labor (Acumoms 2): a randomized, sham-controlled clinical trial.

Authors:  Gary N Asher; Remy R Coeytaux; Wunian Chen; Aimee C Reilly; Yen L Loh; Terry C Harper
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

Review 5.  Postterm pregnancy.

Authors:  M Galal; I Symonds; H Murray; F Petraglia; R Smith
Journal:  Facts Views Vis Obgyn       Date:  2012

6.  Induction of Labor in Primigravid Term Pregnancy with Misoprostol or Dinoprostone: A Comparative Study.

Authors:  Rizwana Arif; Tayaba Mazhar; Mashal Jamil
Journal:  Cureus       Date:  2019-09-24

7.  Comparison of misoprostol and dinoprostone for elective induction of labour in nulliparous women at full term: a randomized prospective study.

Authors:  Evangelos G Papanikolaou; Nikos Plachouras; Aikaterini Drougia; Styliani Andronikou; Christina Vlachou; Theodoros Stefos; Evangelos Paraskevaidis; Konstantinos Zikopoulos
Journal:  Reprod Biol Endocrinol       Date:  2004-09-27       Impact factor: 5.211

8.  Maternal obesity, length of gestation, risk of postdates pregnancy and spontaneous onset of labour at term.

Authors:  F C Denison; J Price; C Graham; S Wild; W A Liston
Journal:  BJOG       Date:  2008-05       Impact factor: 6.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.